Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × INDUSTRY × dalpiciclib × Clear all

Phase

Status

Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

OTHER 13 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Injections 53 Cisplatin 47 Paclitaxel 45 Carboplatin 40 Gemcitabine 37 Docetaxel 37 Capecitabine 34 pembrolizumab 33 Drug Therapy 32 anlotinib 25 Bevacizumab 24 icotinib 23 Fluorouracil 23 Cyclophosphamide 21 Oxaliplatin 18 fludarabine 17 Pemetrexed 16 Irinotecan 16 Temozolomide 15 Leucovorin 15 Cetuximab 14 camrelizumab 13 apatinib 13 Nivolumab 13 Doxorubicin 12 Rituximab 11 Etoposide 11 tesetaxel 10 Trastuzumab 10 SHR-1701 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05515289 2023-03-10

Study of SHR6390 in Renal Insufficiency and Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡